There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on National Health Investors (NHI – Research Report) and QBE Insurance Group Limited (QBEIF – Research Report) with bullish sentiments.
National Health Investors (NHI)
National Health Investors received a Buy rating and a $61.00 price target from BMO Capital analyst John Kim today. The company’s shares closed last Monday at $54.59, close to its 52-week low of $50.88.
According to TipRanks.com, Kim is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for National Health Investors with a $59.00 average price target.
QBE Insurance Group Limited (QBEIF)
The company’s shares closed last Tuesday at $7.54, close to its 52-week low of $7.37.
According to TipRanks.com, Russell is a 2-star analyst with an average return of
Currently, the analyst consensus on QBE Insurance Group Limited is a Strong Buy with an average price target of $10.77, which is a 22.5% upside from current levels. In a report issued on April 13, Credit Suisse also maintained a Buy rating on the stock with a price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on NHI:
- ACADIA Pharmaceuticals (ACAD) Gets a Hold Rating from Berenberg Bank
- ACADIA Pharmaceuticals (ACAD) Gets a Hold Rating from Mizuho Securities
- Carvana Co (CVNA) Receives a Buy from Stifel Nicolaus
- Credit Suisse Sticks to Their Buy Rating for Bank of Queensland Limited (BKQNF)
- Morgan Stanley Sticks to Its Hold Rating for Allkem Limited (OROCF)